IDWeek

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair
October 25, 2023

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

Universal Masking in Health Care Settings: Poised for Return?
October 18, 2023

IDWeek 2023: Infectious disease specialist, Gopi Patel, MD, discusses universal masking in health care settings.

ID Specialist Underscores Vital Role of Vaccination among Health Care Professionals this Flu Season at IDWeek 2023
October 17, 2023

Clinicians must remember the point of vaccines was not to prevent infection, but to decrease severity of illness, says infectious disease specialist Gopi Patel, MD.

ID Specialist to Colleagues: Don’t Pass Your Germs to Your Patients This Flu Season
October 17, 2023

Gopi Patel, MD, emphasizes the importance of promoting vaccination and infection prevention measures among fellow clinicians, as well as patients, this season.

IDWeek 2023 Chair on Primary Care: "Central to Every Health Outcome We Have in the US..."
October 17, 2023

IDWeek chair Heather Yun, MD, observed that "primary care clinicians are out in front of all things," and that job is big and it's hard.

Heather Yun, MD, IDWeek 2023 Chair, Says Emerging Threats May be Bigger than Pathogens
October 16, 2023

IDWeek 2023 chair Yun points to climate change and other human-driven devastation of the biosphere as the global threats that will cause disease at local levels.

IDWeek 2023: Nirsevimab Efficacy Against RSV-LRTI-Associated Hospitalization is Robust Across Infant Subgroups
October 15, 2023

IDWeek 2023. Nirsevimab efficacy was significant across infant subgroups in preventing hospitalization for RSV-LRTI during a first RSV season.

IDWeek 2023: New Data Provide Closer Look at Real-World Utilization of Cabotegravir for HIV PrEP
October 15, 2023

IDWeek 2023. New study found just slightly more than half of prescriptions for cabotegravir for HIV PrEP resulted in at least 1 injection, suggesting limitations in use and access to the injectable HIV integrase inhibitor.

In People Living with HIV, Switch from Oral ART to Long-Acting Injectable Significantly Improved Adherence, Persistence
October 11, 2023

IDWeek 2023: In a large cohort of people living with HIV, those switching from oral ART to long acting CAB+RPV were more than 4x as likely to adhere to the regimen.

Adolescents Prefer Combination Meningococcal Vaccine to Separate MenACWY and MenB Administration a New Study Finds
October 11, 2023

IDWeek 2023: Adolescents expressed a preference for a combination vaccine covering serogroups A, B, C, W, Y of invasive meningococcal disease, reported researchers.